Strategies And Stocks For The Long Run: Ocean Power Technologies, Inc. (OPTT) and Viveve Medical, Inc. (VIVE)

Kirby George H III, President, CEO, bought 10,660 shares of the Ocean Power Technologies, Inc. (NASDAQ:OPTT) in an exchange that happened on November 6th. The stock was bought at an average price of $0.55 per share, amounting to a transaction worth $5,852. The purchase was made public in a document filed with the SEC. Additionally, President, CEO Kirby George H III bought 4,264 shares of this stock in a transaction that took place on November 5th. The stock was bought at an average price of $0.53 per share, for a total exchange amounting to $2,260. After the transaction, the President, CEO Kirby George H III currently holds 128,019 shares of the company’s stock, which is worth approximately $371255.

With this stock price’s latest movement, it is now -88.31% away from its 1-year high and 6.62% higher than its 1-year low price. In the past seven days, the stock price volatility for Ocean Power Technologies, Inc. was 9.25%, whereas its volatility in the past 30 days has been 16.25%. This public company’s stock also has a beta score of 3.48. When the beta value is less/more than 1, it can imply that the stock is less/more volatile than the wider stock market – a metric that traders will surely be keeping tabs on.

Shares of Ocean Power Technologies, Inc. (OPTT) surged 4.69%, amounting to a gain of $0.13 per share, to finish the regular trading session at $2.90 on Friday April 12th, 2019. After beginning the session at $2.75, shares of Ocean Power Technologies, Inc. reached as high as $3.05 during the day, while hitting a 1-day low of $2.72. Trade volume reached 2,197,641 shares against this stock’s average daily volume of 699.75K shares, with a total float of 0.94M. As a consequence of the price increase, Ocean Power Technologies, Inc. now has a current market value of 2.93M.

Viveve Medical, Inc. (NASDAQ:VIVE) added 19.17% to its trading price by the close of the most recent session, jumping from its previous closing price of $0.58 to $0.69. This stock decreased in value by -13.75% during the last 7-day period, and experienced a loss of -21.10% over the past 30-day period. In the past three months, this stock’s price lost by -46.51% , and subtracted -78.23% to its price during the last six months of trading. VIVE demonstrated a yearly price loss of -77.30% , while its year-to-date (YTD) price performance has been down -34.29% . This stock’s price changed by +25.45% compared to its 90-day low, and moved down -48.51% comparing to its 90-day high price.

Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the VIVE stock as “Sell”. In the short-term, Viveve Medical, Inc. (VIVE) has a 20-day average volume of 535,395 shares and short-term indicators sets the VIVE stock as “ 60% Sell ” on average basis. In the medium-term, VIVE stock has a 50-Day average volume of 295,072 shares and medium-term indicators gave the average rating of “ 100% Sell ”, while in the long-term period the stock has a 100-Day average volume of 301,424 shares. On average, long-term indicators rated the stock as “100% Sell ”. The overall picture from all short, medium and long-term indicators sets the VIVE stock as “88% Sell ” on average basis.

Recently, multiple brokerages have sent out reports on VIVE. Stifel, for example, Initiated its rating on shares of Viveve Medical, Inc. to a “Buy”, while setting a $6 price target on shares of the company’s stock, according to a research note from Tuesday April 17th, 2018. Northland Capital Initiated their target price for this stock to $8, while giving the stock a “Outperform” rating, as stated in a research report from Friday, January 5th, 2018. Mizuho, on the other hand, Initiated a “Buy” rating on this stock, while posting a $10 price target on shares of this company’s stock in a research note dated Friday, November 17th, 2017.

In other news related to Viveve Medical, Inc. stock, 68.49% shares of VIVE held by institutions. The total number of institutions who held the VIVE shares was 48, according to most recent SEC filling. During the past quarter, total 31,755,969 shares held by institutions with the net change of -31,076 shares. In the meantime, 0 new institutions bought the shares of Viveve Medical, Inc. for the first time and 1 institutions sold all their holdings in the company’s common stock. 0 institutions increased their investment in the VIVE stock and 3 institutions decreased their investment in the Viveve Medical, Inc. (VIVE)’s stock during the last quarter.